Log in to save to my catalogue

A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cance...

A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cance...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c74e34d161c444469af0643c90b25955

A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer

About this item

Full title

A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2017-11, Vol.8 (1), p.1390-14, Article 1390

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Paclitaxel (PTX) is among the most commonly used first-line drugs for cancer chemotherapy. However, its poor water solubility and indiscriminate distribution in normal tissues remain clinical challenges. Here we design and synthesize a highly water-soluble nucleolin aptamer-paclitaxel conjugate (NucA-PTX) that selectively delivers PTX to the tumor...

Alternative Titles

Full title

A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c74e34d161c444469af0643c90b25955

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c74e34d161c444469af0643c90b25955

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-017-01565-6

How to access this item